Remove Clinic Remove Pharmaceutical Remove Radiation
article thumbnail

RefleXion Acquires Global Rights to Radiopharmaceutical Molecule from 3B Pharmaceuticals to Treat High Unmet Need Cancers

Imaging Technology

We are excited, in collaboration with 3BP and others, to advance this molecule through clinical testing to commercialization.” This milestone ushers in a new era of autonomous radiotherapy where the biology of the tumor directs where to deliver the radiation dose. For more information: [link] Wednesday, September 20, 2023 - 09:56

article thumbnail

First Participant Treated Using NorthStar Medical Radioisotopes’ Electron Accelerator-produced Copper-67 (Cu-67) in Clarity Pharmaceuticals’ Phase I/IIa Theranostic Clinical Trial Investigating Cu-67 SARTATE for Treatment of Neuroblastoma

Imaging Technology

Administration of the therapeutic dose took place as part of an ongoing Phase I/IIa theranostic clinical trial conducted by Clarity Pharmaceuticals to investigate the safety and efficacy of Cu-67 SARTATE in pediatric patients with high-risk neuroblastoma.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

TeleDaaS Launches as Premier Provider of Dosimetry as a Service for Clinical Research Organizations

Imaging Technology

TeleDaaS specializes in delivering clinical-grade, precision-based dosimetry analysis and treatment plans to clinical research organizations (CROs) and pharmaceutical manufacturers. The life expectancy of patients on the personalized dosimetry arm of the trial increased to 26.6 months from 10.7

Clinic 78
article thumbnail

NorthStar Medical Radioisotopes and Curadh MTR Announce a Strategic Long Term Supply Agreement for Therapeutic Radioisotope Actinium-225 (Ac-225)

Imaging Technology

Curadh), a global MTR focused clinical, research and advisory organization, announced the signing of a strategic long term supply agreement for the therapeutic radioisotope non-carrier added (n.c.a.) Ac-225 to Curadh for use in its pioneering molecularly targeted radiation (MTR) programs for the treatment of common lethal tumors. “We

Medical 98
article thumbnail

TeleDaaS debuts as dosimetry provider at RSNA 2023

AuntMinnie

The Evanston, IL-based company specializes in delivering dosimetry analysis and treatment plans to clinical research organizations and pharmaceutical manufacturers. The company offers scalable dosimetry services that integrate with existing imaging workflows in hospitals and cancer treatment research facilities.

article thumbnail

The rise of theranostics: Part 5 -- Advice from center administrators

AuntMinnie

Beyder, along with Vikas Prasad, MD, PhD, and BJH/WU Radiation Oncology all played an integral role in launching the SNMMI radiopharmaceutical therapy (RPT) comprehensive center of excellence at WU, Barnes-Jewish Hospital, and Siteman Cancer Center last year. Involve radiation safety early in your therapy center development. "If

article thumbnail

TAE Life Sciences Promotes Rob Hill to CEO 

Imaging Technology

The company is a pre-clinical stage biotech company focused on advancing the field of radiation oncology through accelerator-based Boron Neutron Capture Therapy (BNCT), based in Santa Monica, CA. Hill joined TAE Life Sciences as Chief Operating Officer (COO) in October 2018.